Drug-coated Balloons in the Treatment of Coronary Artery Disease: Results from the Drug Eluting Technologies Evaluation & Current Trends (DETECT) Survey
Interventional Cardiology Reviews Research Resources · 10.08.2026
DOI: 10.15420/icr.2026.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interventional Cardiology Reviews Research Resources, online erschienen am 10.08.2026. Verfasst von Daniel O'Callaghan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Mater Private Network Dublin, Ireland. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Drug-coated balloons (DCBs) are increasingly used in percutaneous coronary intervention (PCI) but there are limited data available on practice patterns. Our survey evaluated the views of interventional cardiologists with respect to various clinical and technical aspects of DCB angioplasty.
Methods
A voluntary, online survey involving 13 questions – the Drug Eluting Technologies Evaluation & Current Trends (DETECT) Clinical Practice Survey – was conducted in two waves: a census of Irish interventional cardiologists in April 2025 and an onsite survey at the EuroPCR Congress in May 2025. The question topics included indications for DCB use, device selection factors, dual antiplatelet therapy (DAPT) duration and intravascular imaging use. Respondent characteristics were recorded.
Results
A total of 136 respondents (126 consultants, 10 fellows) from 39 countries (60 Ireland, 76 EuroPCR) participated in the survey. The survey revealed that most consider a DCB for in-stent restenosis (ISR; 99%), small vessel disease (95%) and bifurcation lesions (77%). A lower proportion consider a DCB strategy in chronic total occlusion (29%), any vessel size (21%) or acute coronary syndrome (17%). No differences by level of interventional experience (>10 years,
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Research Institute, Mater Private Network Dublin, Ireland.
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences Dublin, Ireland.
ORCID-Profile: Daniel O'Callaghan, J J Coughlan, Himanshu Rai, Niall Connolly, Muhammad Ali Jawed, Rory Durand, Róisín Colleran, Robert A Byrne
Zitieren
APA
O'Callaghan, D., Coughlan, J. J., Rai, H., Connolly, N., Jawed, M. A., Durand, R., Spence, M. S., Colleran, R., Hanratty, C. G., & Byrne, R. A. (2026). Drug-coated Balloons in the Treatment of Coronary Artery Disease: Results from the Drug Eluting Technologies Evaluation & Current Trends (DETECT) Survey. Interventional Cardiology Reviews Research Resources. https://doi.org/10.15420/icr.2026.03
Vancouver
O'Callaghan D, Coughlan JJ, Rai H, Connolly N, Jawed MA, Durand R, et al. Drug-coated Balloons in the Treatment of Coronary Artery Disease: Results from the Drug Eluting Technologies Evaluation & Current Trends (DETECT) Survey. Interventional Cardiology Reviews Research Resources. 2026. doi:10.15420/icr.2026.03
BibTeX
@article{OCallaghan2026,
author = {O'Callaghan, Daniel and Coughlan, J J and Rai, Himanshu and Connolly, Niall and Jawed, Muhammad Ali and Durand, Rory and Spence, Mark S and Colleran, Róisín and Hanratty, Colm G and Byrne, Robert A},
title = {Drug-coated Balloons in the Treatment of Coronary Artery Disease: Results from the Drug Eluting Technologies Evaluation & Current Trends (DETECT) Survey},
journal = {Interventional Cardiology Reviews Research Resources},
year = {2026},
doi = {10.15420/icr.2026.03}
}
EUVIMED